Calcipotriol/betamethasone dipropionate ointment in mild-to-moderate paediatric psoriasis: long-term daily clinical practice data in a prospective cohort

Abstract

In this daily clinical practice study in paediatric psoriasis, calcipotriol/betamethasone dipropionate ointment initially improved mild-to-moderate psoriasis and then maintained its effect. In addition, it improved QoL, with few adverse events.

References

Page 1

	Year	Citations
Severe Psoriasis – Oral Therapy with a New Retinoid T Fredriksson, U. Pettersson Dermatology	1978	2.7K
The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use M.S. Lewis‐Jones, A.Y. Finlay British Journal of Dermatology Quality Of LifeDraft QuestionnaireDisabilityDermatologyChild Assessment	2010	1K
Definition of treatment goals for moderate to severe psoriasis: a European consensus Ulrich Mrowietz, Knud Kragballe, Kristian Reich, Archives of Dermatological Research	2010	868
A Comparative Study of Pediatric Onset Psoriasis with Adult Onset Psoriasis S. P. Raychaudhuri, Jeffry Gross Pediatric Dermatology	2000	308
Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial Lyn Guenther, F. Cambazard, P.C.M. van de Kerkhof, British Journal of Dermatology	2002	174
Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis Kim Papp, Lyn Guenther, B. Boyden, Journal of the American Academy of Dermatology Early OnsetMedicinePharmacologyClinical DermatologyDermatology	2003	164
A New Calcipotriol/Betamethasone Dipropionate Formulation (Daivobet<sup>TM</sup>) Is an Effective Once-Daily Treatment for Psoriasis vulgaris Roland Kaufmann, A. Bibby, Robert Bissonnette, Dermatology	2002	163
A New Calcipotriol/Betamethasone Formulation with Rapid Onset of Action was Superior to Monotherapy with Betamethasone Dipropionate or Calcipotriol in Psoriasis Vulgaris W.S. Douglas, Yves Poulin, J. Decroix, Acta Dermato Venereologica OphthalmologyRapid OnsetMedicinePharmacologyClinical Dermatology	2002	159
The Children's Dermatology Life Quality Index: validation of the cartoon version S.A. Holme, Irene Man, Jozie Sharpe, British Journal of Dermatology	2003	140
A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet<sup>®</sup>/Daivobet<sup>®</sup>/Taclonex<sup>®</sup>) in the treatment of psoriasis vulgaris Knud Kragballe, Joar Austad, Larry D. Barnes, British Journal of Dermatology	2006	138

Page 1